Article
Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine.
Vaccine - 1 Aug 1990
Saluzzo J F, Smith J F
Abstract excerpt
A live-attenuated vaccine for Rift Valley fever virus (RVFV), MP-12, has been developed recently by undirected, serial mutagenesis of a RVFV strain (ZH548) isolated during the 1977 epidemic in Egypt. In the present study, the mutations responsible for attenuation of this virus have been examined...
Topics
- Animals
- Antibodies, Monoclonal
- Antigens, Viral
- Bunyaviridae
- Chromosome Mapping
- Clone Cells
- Humans
- Mice
- Mutation
- Phenotype
- Rift Valley fever virus
- Temperature
- Vaccines, Attenuated
